Class 4 Caution in use- Loceryl nail lacquer

Galderma (U.K.) Limited has informed the MHRA that a pallet of Loceryl 5% w/v Medicated Nail Lacquer from a batch licensed only for distribution in Ireland has been inadvertently placed into the UK supply chain due to a warehousing error at their UK pre-wholesaler. Although Loceryl is a registered medicine in both Ireland and the UK, there are differences between these products in the product labelling and Patient Information Leaflet (PIL) packaged with the medicine.

MHRA drug alert date: 29th August 2023

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-galderma-uk-limited-loceryl-5-percent-w-slash-v-medicated-nail-lacquer-5-dot-0-ml-el-23-a-slash-31?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=9a7e9437-f55e-4f24-82a6-d91ff2f6df4f&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

If you require more information, have further medical information enquiries (including replacement PIL enquiries) then please e-mail: medinfo.uk@galderma.com. For stock control queries, please contact: sales.uk@galderma.com